Literature DB >> 29404352

Severe sepsis and cardiac arrhythmias.

Muhammad Shahreyar1, Regina Fahhoum2, Oluwaseun Akinseye1, Sanjay Bhandari2, Geetanjali Dang3, Rami N Khouzam1.   

Abstract

BACKGROUND: Although sepsis is a known risk factor for cardiac arrhythmias, data on incidence and outcomes of atrial and ventricular arrhythmias in severe sepsis is limited. The purpose of this study is to examine the association of severe sepsis with cardiac arrhythmias and their impact on outcome in this patient population.
METHODS: We used hospital discharge data from the Nationwide Inpatient Sample (NIS) during the year 2012. All patients 18 years or older were included in the study. The International Classification of Diseases-Clinical Modification, 9th revision (ICD-9-CM) code was used to identify patients with discharge diagnosis of severe sepsis, atrial fibrillation (A Fib), atrial flutter (AFL), ventricular fibrillation (VF) arrest and non-ventricular fibrillation (non-VF) arrest. In order to study the association of arrhythmias with severe sepsis, two groups were defined: group a-with severe sepsis was compared to group b-without severe sepsis. Univariate and multivariate logistic regression methods were used to adjust for potential confounding factors and variables associated with cardiac arrhythmias were determined.
RESULTS: A total of 30,712,524 NIS hospital discharges (weighted for national estimate) were included in our study, of which 1,756,965 (5.7%) had severe sepsis. On multivariate analysis, after adjusting for potential confounders, severe sepsis was associated with higher risk of A Fib (OR, 1.23; 95% CI, 1.21-1.24), AFL (OR, 1.34; 95% CI, 1.30-1.40), VF arrest (OR, 2.58; 95% CI, 2.38-2.79) (OR, 3.31; 95% CI, 3.07-3.57) and non-VF arrest (OR, 4.91; 95% CI, 4.74-5.07). In the severe sepsis group, cardiac arrhythmia was associated with higher in-hospital mortality (OR, 1.41; 95% CI, 1.37-1.45), length of stay (LOS) >75% quartile (OR, 1.50; 95% CI, 1.46-1.53) and total hospital charges >75% quartile (OR, 1.37; 95% CI, 1.34-1.41). Advanced age, male sex, ischemic heart disease, diabetes mellitus (DM), congestive heart failure (CHF), valvular heart disease, respiratory failure, mechanical ventilation and use of vasopressors were independently associated with cardiac arrhythmias.
CONCLUSIONS: Patients with severe sepsis are at high risk of atrial and life threatening ventricular arrhythmias. Despite adjustment for potential confounding factors, patients hospitalized with severe sepsis carry a significantly higher risk for cardiac arrest and increased mortality.

Entities:  

Keywords:  Sepsis; atrial arrhythmias; cardiac arrest; cardiac arrhythmias; ventricular arrhythmias

Year:  2018        PMID: 29404352      PMCID: PMC5787725          DOI: 10.21037/atm.2017.12.26

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


  33 in total

1.  Tachyarrhythmias in a surgical intensive care unit: a case-controlled epidemiologic study.

Authors:  H Knotzer; A Mayr; H Ulmer; W Lederer; W Schobersberger; N Mutz; W Hasibeder
Journal:  Intensive Care Med       Date:  2000-07       Impact factor: 17.440

2.  Sequential changes in autonomic regulation of cardiac myocytes after in vivo endotoxin injection in rat.

Authors:  N Abi-Gerges; B Tavernier; A Mebazaa; V Faivre; X Paqueron; D Payen; R Fischmeister; P F Méry
Journal:  Am J Respir Crit Care Med       Date:  1999-10       Impact factor: 21.405

3.  Incidence and type of cardiac arrhythmias in critically ill patients: a single center experience in a medical-cardiological ICU.

Authors:  P Reinelt; G D Karth; A Geppert; G Heinz
Journal:  Intensive Care Med       Date:  2001-09       Impact factor: 17.440

4.  Supraventricular arrhythmias in intensive care unit patients: short and long-term consequences.

Authors:  Sergei Goodman; Taras Shirov; Charles Weissman
Journal:  Anesth Analg       Date:  2007-04       Impact factor: 5.108

Review 5.  Inflammation in the genesis and perpetuation of atrial fibrillation.

Authors:  Mads D M Engelmann; Jesper Hastrup Svendsen
Journal:  Eur Heart J       Date:  2005-06-23       Impact factor: 29.983

6.  Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.

Authors:  A S Go; E M Hylek; K A Phillips; Y Chang; L E Henault; J V Selby; D E Singer
Journal:  JAMA       Date:  2001-05-09       Impact factor: 56.272

7.  Incidence and prognosis of sustained arrhythmias in critically ill patients.

Authors:  Djillali Annane; Véronique Sébille; Denis Duboc; Jean-Yves Le Heuzey; Nicolas Sadoul; Erik Bouvier; Eric Bellissant
Journal:  Am J Respir Crit Care Med       Date:  2008-04-03       Impact factor: 21.405

8.  Paroxysmal atrial fibrillation in critically ill patients with sepsis.

Authors:  Salam Salman; Abubakr Bajwa; Ognjen Gajic; Bekele Afessa
Journal:  J Intensive Care Med       Date:  2008-04-28       Impact factor: 3.510

9.  Incidence and risk factors of atrial fibrillation in a surgical intensive care unit.

Authors:  Philippe Seguin; Thomas Signouret; Bruno Laviolle; Bernard Branger; Yannick Mallédant
Journal:  Crit Care Med       Date:  2004-03       Impact factor: 7.598

10.  Septic cardiomyopathy - A not yet discovered cardiomyopathy?

Authors:  Ursula Muller-Werdan; Michael Buerke; Henning Ebelt; Konstantin M Heinroth; Anja Herklotz; Harald Loppnow; Martin Ruß; Frithjof Schlegel; Axel Schlitt; Hendrik B Schmidt; Gerold Söffker; Karl Werdan
Journal:  Exp Clin Cardiol       Date:  2006
View more
  19 in total

1.  Novel functions of macrophages in the heart: insights into electrical conduction, stress, and diastolic dysfunction.

Authors:  Florian Leuschner; Matthias Nahrendorf
Journal:  Eur Heart J       Date:  2020-03-01       Impact factor: 29.983

2.  The protective effect and mechanism of lentinan on acute kidney injury in septic rats.

Authors:  Xiaoping Li; Wanfen Zhang; Ping Li; Guoyuan Lu
Journal:  Ann Transl Med       Date:  2020-07

Review 3.  Epicardial adipose tissue as a mediator of cardiac arrhythmias.

Authors:  Kiran Haresh Kumar Patel; Taesoon Hwang; Curtis Se Liebers; Fu Siong Ng
Journal:  Am J Physiol Heart Circ Physiol       Date:  2021-12-10       Impact factor: 4.733

4.  Atrial Fibrillation in Patients with Septic Shock: A One-Year Observational Pilot Study.

Authors:  Irene Steinberg; Etrusca Brogi; Lorenza Pratali; Danila Trunfio; Greta Giuliano; Elena Bignami; Francesco Forfori
Journal:  Turk J Anaesthesiol Reanim       Date:  2019-01-24

5.  Molecular Regulatory Pathways Link Sepsis With Metabolic Syndrome: Non-coding RNA Elements Underlying the Sepsis/Metabolic Cross-Talk.

Authors:  Chanan Meydan; Uriya Bekenstein; Hermona Soreq
Journal:  Front Mol Neurosci       Date:  2018-06-05       Impact factor: 5.639

6.  Incidence, treatment and mortality of new-onset atrial fibrillation patients at the intensive care unit.

Authors:  Marinus Van Hulst; Robert G Tieleman; Maartje S Jacobs; Bert Loef; Auke C Reidinga; Maarten J Postma
Journal:  Open Heart       Date:  2020-04-06

Review 7.  COVID-19 Management and Arrhythmia: Risks and Challenges for Clinicians Treating Patients Affected by SARS-CoV-2.

Authors:  Alexander Carpenter; Owen J Chambers; Aziza El Harchi; Richard Bond; Oliver Hanington; Stephen C Harmer; Jules C Hancox; Andrew F James
Journal:  Front Cardiovasc Med       Date:  2020-05-05

8.  Systemic Inflammation Rapidly Induces Reversible Atrial Electrical Remodeling: The Role of Interleukin-6-Mediated Changes in Connexin Expression.

Authors:  Pietro Enea Lazzerini; Franco Laghi-Pasini; Maurizio Acampa; Ujala Srivastava; Iacopo Bertolozzi; Beatrice Giabbani; Francesco Finizola; Francesca Vanni; Aleksander Dokollari; Mariarita Natale; Gabriele Cevenini; Enrico Selvi; Nicola Migliacci; Massimo Maccherini; Mohamed Boutjdir; Pier Leopoldo Capecchi
Journal:  J Am Heart Assoc       Date:  2019-08-19       Impact factor: 5.501

9.  Single-cell transcriptomics reveals the alteration of peripheral blood mononuclear cells driven by sepsis.

Authors:  Miaoyun Wen; Gengxin Cai; Jingkun Ye; Xinqiang Liu; Hongguang Ding; Hongke Zeng
Journal:  Ann Transl Med       Date:  2020-02

10.  Ruxolitinib protects lipopolysaccharide (LPS)-induced sepsis through inhibition of nitric oxide production in mice.

Authors:  Li Li; Xingfeng He; Xingtong Wang; Yu Sun; Guosheng Wu; He Fang; Chen Wang; Pengfei Luo; Zhaofan Xia
Journal:  Ann Transl Med       Date:  2020-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.